Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C
Clinical trial NCT04666298 · COMPLETED
Trial details
- NCT number
- NCT04666298
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2022-04-18
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.